ESErrol. L. G. Samuel

Errol. L. G. Samuel

*This is an algorithmically generated author record based on publicly available information.

Errol. L. G. Samuel has a total of 181 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • SuFEx Cyclization Enables DNA-Encoded Macrocyclic Peptide Libraries for Drug Discovery

    by Tianxiong Mi, Lijun Fan, Amber Hackler, Diego B. Diaz, Chang Qi, Errol L. G. Samuel, Qi Gao, Tao Meng, Xingjian Xu, Erwin G. Abucayon, et al.

    Rapid, aqueous macrocyclization strategies that proceed in high conversion are valuable for ultralarge macrocyclic peptide (MP) library synthesis via display and DNA-encoded library (DEL) technology. Here we report an on-DNA macrocyclization based on sulfur(VI) fluoride exchange (SuFEx) that unites above features. This approach embeds a phenol and an aryl sulfonyl fluoride within a DNA-tagged peptide to accelerate SuFEx and trigger intramolecular cyclization immediately upon dissolution in basic aqueous buffer. MPs ranging from 15 to 52 membered rings bearing diverse amino acids were synthesized efficiently. The on-DNA conditions readily translate off DNA to furnish sulfonate and sulfonamide linked MPs. NMR analyses showed SuFEx-derived biaryl linkers act as conformational tuner: sequential changes in aryl substitution and linker length shift backbone conformations from extended strands to rigid turns. Leveraging this chemistry, we designed and synthesized ultralarge MP libraries via DEL technology. DEL screening followed by off-DNA hit validation identified a potent, de novo MP inhibitor of receptor-interacting serine/threonine kinase 1 (RIPK1). Collectively, these findings establish SuFEx cyclization as a robust, DEL-compatible strategy for programmable macrocycle design and drug discovery.

  • HELMify: A Hybrid Rule- and LLM-Based Generator of Peptide Monomer HELM Names

    by Robert P. Sheridan, Rajvi Shah, Kathryn McGarty, Michael Garrigou, Charles Jayne, Andrew Roberts, Gregory S. Bryman, Liying Zhang, Errol L.G. Samuel

    HELM is a hierarchical notation system for biopolymers that is an increasingly popular choice for representing peptides. In this system, each monomer name must uniquely identify a single monomer, and until now, chemists have named peptide monomers by hand using a limited set of rules. As the chemical space of monomers is practically unlimited, this naming process is too time-consuming to be done by chemists and is prone to inconsistency. To address this bottleneck, we developed a public benchmark data set for this task and two complementary automated naming approaches for HELM name generation: a zone-based namer, which relies on hand-curated dictionaries of substructures, and a generative AI namer, which relies on a pretrained Large Language Model (LLM) with chemistry world knowledge. We evaluated both approaches on a set of publicly disclosed alpha amino acids. For a time-split test set, the zone-based namer produced usable names for 84% of cases: 54% matched the human-generated name exactly, and an additional 30% did not match but were interpretable as the correct structure. The LLM-based namer produced usable names for 42% of cases: 33% of the names matched the human-generated name exactly, and an additional 9% were nonidentical but still interpretable as the correct structure. In another 49% of LLM-generated cases, the outputs were considered close matches, and while not directly usable, they can still inform the generation of correct names. The zone-based namer is deterministic, fast, and independent of any previous names, explicitly handling zone order and chirality. The LLM-based namer can generalize from human-named examples to propose names for novel chemical groups, helping fill library gaps. Together, the approaches offer complementary coverage: rules-based precision and speed paired with data-driven flexibility for novel moieties. Combining the strengths of both approaches paves the way for an automated peptide monomer naming process that can accelerate research by (i) helping the community establish standardized guidelines for the rapidly expanding noncanonical amino acid (ncAA) space, (ii) streamlining integration with synthesis planning, inventory management, and analysis pipelines, (iii) enabling more consistent annotation in ELNs, databases, and publications, and (iv) facilitating cross-lab replication and data exchange. Together, these advances can expedite method development, reduce ambiguity in collaboration, and ultimately support the discovery of novel peptides with improved drug-like properties.

  • Open Access

    HELMify: A Hybrid Rule-and LLM-Based Generator of Peptide Monomer HELM Names

    by Robert P Sheridan, Rajvi Shah, Kathryn Mcgarty, Michael Garrigou, Charles Jayne, Andrew Roberts, Gregory Bryman, Liying Zhang, Errol L G Samuel

    HELM is a hierarchical notation system for biopolymers that is an increasingly popular choice for representing peptides. In this system, each monomer name must uniquely identify a single monomer, and until now, chemists have named peptide monomers by hand using a limited set of rules. As the chemical space of monomers is practically unlimited, this naming process is too time consuming to be done by chemists, and is prone to inconsistency. To address this bottleneck, we developed two complementary automated naming approaches for HELM name generation: a zone-based namer which relies on hand-curated dictionaries of substructures, and a generative AI namer which relies on a pre-trained Large Language Model (LLM) with chemistry world knowledge. We evaluated both approaches on a set of publicly disclosed alpha amino acids. For a time-split test set, the zone-based namer produced usable names for 84% of cases: 54% matched the human-generated name exactly, and an additional 30% did not match, but were interpretable as the correct structure. The LLM-based namer produced usable names for 42% of cases: 33% of the names matched the human-generated name exactly, and an additional 9% were non-identical but still interpretable as the correct structure. In another 49% of cases, the outputs were considered close matches, and while not directly usable, they can still inform the generation of correct names. The zone-based namer is deterministic, fast, and independent of any previous names, explicitly handling zone order and chirality. The LLM-based namer can generalize from human‑named examples to propose names for novel chemical groups, helping fill library gaps. Together, the approaches offer complementary coverage: rules‑based precision and speed paired with data‑driven flexibility for novel moieties. Combining the strengths of both approaches paves the way for an automated peptide monomer naming process that can accelerate research by: (i) helping the community establish standardized guidelines for the rapidly expanding non-canonical amino acid (ncAA) space; (ii) streamlining integration with synthesis planning, inventory management, and analysis pipelines (iii) enabling more consistent annotation in ELNs, databases, and publications; and (iv) facilitating cross-lab replication and data exchange. Together, these advances can expedite method development, reduce ambiguity in collaboration, and ultimately support the discovery of novel peptides with improved drug-like properties.

  • Open Access

    Processing binding data using an open-source workflow

    by Errol L. G. Samuel, Secondra L. Holmes, Damian W. Young

    The thermal shift assay (TSA)—also known as differential scanning fluorimetry (DSF), thermofluor, and Tm shift—is one of the most popular biophysical screening techniques used in fragment-based ligand discovery (FBLD) to detect protein–ligand interactions. By comparing the thermal stability of a target protein in the presence and absence of a ligand, potential binders can be identified. The technique is easy to set up, has low protein consumption, and can be run on most real-time polymerase chain reaction (PCR) instruments. While data analysis is straightforward in principle, it becomes cumbersome and time-consuming when the screens involve multiple 96- or 384-well plates. There are several approaches that aim to streamline this process, but most involve proprietary software, programming knowledge, or are designed for specific instrument output files. We therefore developed an analysis workflow implemented in the Konstanz Information Miner (KNIME), a free and open-source data analytics platform, which greatly streamlined our data processing timeline for 384-well plates. The implementation is code-free and freely available to the community for improvement and customization to accommodate a wide range of instrument input files and workflows. Graphical Abstract


  • Design and construction of a stereochemically diverse piperazine-based DNA-encoded chemical library

    by Srinivas Chamakuri, Mee-Kyung Chung, Errol L.G. Samuel, Kevin A. Tran, Ying-Chu Chen, Pranavanand Nyshadham, Conrad Santini, Martin M. Matzuk, Damian W. Young


  • Open Access

    Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation

    by Redwan Huq, Errol L. G. Samuel, William K. A. Sikkema, Lizanne G. Nilewski, Thomas Lee, Mark R. Tanner, Fatima S. Khan, Paul C. Porter, Rajeev B. Tajhya, Rutvik S. Patel, et al.

    Autoimmune diseases mediated by a type of white blood cell—T lymphocytes—are currently treated using mainly broad-spectrum immunosuppressants that can lead to adverse side effects. Antioxidants represent an alternative approach for therapy of autoimmune disorders; however, dietary antioxidants are insufficient to play this role. Antioxidant carbon nanoparticles scavenge reactive oxygen species (ROS) with higher efficacy than dietary and endogenous antioxidants. Furthermore, the affinity of carbon nanoparticles for specific cell types represents an emerging tactic for cell-targeted therapy. Here, we report that nontoxic poly(ethylene glycol)-functionalized hydrophilic carbon clusters (PEG-HCCs), known scavengers of the ROS superoxide (O2•−) and hydroxyl radical, are preferentially internalized by T lymphocytes over other splenic immune cells. We use this selectivity to inhibit T cell activation without affecting major functions of macrophages, antigen-presenting cells that are crucial for T cell activation. We also demonstrate the in vivo effectiveness of PEG-HCCs in reducing T lymphocyte-mediated inflammation in delayed-type hypersensitivity and in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Our results suggest the preferential targeting of PEG-HCCs to T lymphocytes as a novel approach for T lymphocyte immunomodulation in autoimmune diseases without affecting other immune cells.


  • Open Access

    Characterization of a novel MR‐detectable nanoantioxidant that mitigates the recall immune response

    by Taeko Inoue, Deric M. Griffin, Redwan Huq, Errol L. G. Samuel, Simone H. Ruano, Gary Stinnett, Tabassum J. Majid, Christine Beeton, James M. Tour, Robia G. Pautler

    In many human diseases, the presence of inflammation is associated with an increase in the level of reactive oxygen species (ROS). The resulting state of oxidative stress is highly detrimental and can initiate a cascade of events that ultimately lead to cell death. Thus, many therapeutic attempts have been focused on either modulating the immune system to lower inflammation or reducing the damaging caused by ROS. Berlin et al. reported the development of a novel nanoantioxidant known as poly(ethylene glycol)‐functionalized‐hydrophilic carbon clusters (PEG‐HCCs). They showed that PEG‐HCCs could be targeted to cancer cells, utilized as a drug delivery vector, and can even be visualized ex vivo. Our work here furthers this work and characterizes Gd‐DTPA conjugated PEG‐HCCs and explores the potential for in vivo tracking of T cells in live mice. We utilized a mouse model of delayed‐type hypersensitivity (DTH) to assess the immunomodulatory effects of PEG‐HCCs. The T1‐agent Gd‐DTPA was then conjugated to the PEG‐HCCs and T1 measurements, and T1‐weighted MRI of the modified PEG‐HCCs was done to assess their relaxivity. We then assessed if PEG‐HCCs could be visualized both ex vivo and in vivo within the mouse lymph node and spleen. Mice treated with PEG‐HCCs showed significant improvements in the DTH assay as compared to the vehicle (saline)‐treated control. Flow cytometry demonstrated that splenic T cells are capable of internalizing PEG‐HCCs whereas fluorescent immunohistochemistry showed that PEG‐HCCs are detectable within the cortex of lymph nodes. Finally, our nanoantioxidants can be visualized in vivo within the lymph nodes and spleen of a mouse after addition of the Gd‐DTPA. PEG‐HCCs are internalized by T cells in the spleen and can reduce inflammation by suppression of a recall immune response. PEG‐HCCs can be modified to allow for both in vitro and in vivo visualization using MRI. © 2016 The Authors. NMR in Biomedicine published by John Wiley & Sons Ltd.


  • Open Access

    Mechanistic Study of the Conversion of Superoxide to Oxygen and Hydrogen Peroxide in Carbon Nanoparticles

    by Almaz S. Jalilov, Chenhao Zhang, Errol L. G. Samuel, William K. A. Sikkema, Gang Wu, Vladimir Berka, Thomas A. Kent, Ah-Lim Tsai, James M. Tour

    Hydrophilic carbon clusters (HCCs) are oxidized carbon nanoparticles with a high affinity for electrons. The electron accepting strength of HCCs, employing the efficient conversion of superoxide (O2•–) to molecular oxygen (O2) via single-electron oxidation, was monitored using cyclic voltammetry and electron paramagnetic resonance spectroscopy. We found that HCCs possess O2 reduction reaction (ORR) capabilities through a two-electron process with the formation of H2O2. By comparing results from aprotic solvents to those obtained from ORR activity in aqueous media, we propose a mechanism for the origin of the antioxidant and superoxide dismutase mimetic properties of poly(ethylene glycolated) hydrophilic carbon clusters (PEG-HCCs).


  • Open Access

    Biocompatibility of reduced graphene oxide nanoscaffolds following acute spinal cord injury in rats

    by Andrew Jea, AliH Palejwala, JaredS Fridley, JavierA Mata, ErrolL. G. Samuel, ThomasG Luerssen, Laszlo Perlaky, ThomasA Kent, JamesM Tour

    Graphene has unique electrical, physical, and chemical properties that may have great potential as a bioscaffold for neuronal regeneration after spinal cord injury. These nanoscaffolds have previously been shown to be biocompatible in vitro; in the present study, we wished to evaluate its biocompatibility in an in vivo spinal cord injury model. Graphene nanoscaffolds were prepared by the mild chemical reduction of graphene oxide. Twenty Wistar rats (19 male and 1 female) underwent hemispinal cord transection at approximately the T2 level. To bridge the lesion, graphene nanoscaffolds with a hydrogel were implanted immediately after spinal cord transection. Control animals were treated with hydrogel matrix alone. Histologic evaluation was performed 3 months after the spinal cord transection to assess in vivo biocompatibility of graphene and to measure the ingrowth of tissue elements adjacent to the graphene nanoscaffold. The graphene nanoscaffolds adhered well to the spinal cord tissue. There was no area of pseudocyst around the scaffolds suggestive of cytotoxicity. Instead, histological evaluation showed an ingrowth of connective tissue elements, blood vessels, neurofilaments, and Schwann cells around the graphene nanoscaffolds. Graphene is a nanomaterial that is biocompatible with neurons and may have significant biomedical application. It may provide a scaffold for the ingrowth of regenerating axons after spinal cord injury.


  • Top Cited Papers
    Open Access

    Atomic cobalt on nitrogen-doped graphene for hydrogen generation

    by Huilong Fei, Juncai Dong, M. Josefina Arellano-Jiménez, Gonglan Ye, Nam Dong Kim, Errol L.G. Samuel, Zhiwei Peng, Zhuan Zhu, Fan Qin, Jiming Bao, et al.

    Reduction of water to hydrogen through electrocatalysis holds great promise for clean energy, but its large-scale application relies on the development of inexpensive and efficient catalysts to replace precious platinum catalysts. Here we report an electrocatalyst for hydrogen generation based on very small amounts of cobalt dispersed as individual atoms on nitrogen-doped graphene. This catalyst is robust and highly active in aqueous media with very low overpotentials (30 mV). A variety of analytical techniques and electrochemical measurements suggest that the catalytically active sites are associated with the metal centres coordinated to nitrogen. This unusual atomic constitution of supported metals is suggestive of a new approach to preparing extremely efficient single-atom catalysts.